DLPN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress DMRC Q1 2026 Earnings EPS Surpasses Estimates with 5267 Beat AFLAC Q1 2026 Earnings EPS Miss Estimates Amid Stable Operations Vaxcyte PCVX Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Gains on Pipeline Confidence VNET Q4 2025 Earnings Record EPS Beat on Surprise Profitability Outset Medical Q1 2026 Earnings EPS Misses Estimates as Stock Inches Higher DRH Q1 2026 Earnings Strong EPS Beat Amidst Operational Discipline AVGO Q1 2026 Earnings Slight EPS Miss Amid Mixed Signals Canada Goose GOOS Q1 2026 Earnings EPS Miss Amidst Quiet Market Response OPCH Q1 2026 Earnings EPS Beats Estimates by 546 Amid Revenue Data Unavailability ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent Profound Medical Q1 2026 Earnings EPS Beats Estimates Stock Declines